Please login to the form below

Not currently logged in

New GMC Chair takes up office

Professor Peter Rubin succeeds Sir Graeme Catto as Chair of the UK's General Medical Council

Professor Peter Rubin succeeds Sir Graeme Catto as Chair of the UK's General Medical Council (GMC).

Professor Rubin is Professor of Therapeutics and Honorary Consultant Physician at Nottingham University Hospitals. Professor Rubin has spent much of his career specialising in the difficulties of women during pregnancy and continues to be involved in front-line medicine. He was Chair of the GMC Education Committee from 2002-2008, Chair of the Post Graduate Medical Education and Training Board (PMETB) from 2005-2008 and Dean of the Faculty of Medicine and Health Sciences at the University of Nottingham from 1997 - 2003.

The GMC's reconstituted Council (with effect from) January 1, 2009 has, for the first time, an equal representation of lay and medical members. The GMC says that the composition of its Council reflects the GMC's key interest groups: patients and the public; doctors; the NHS and other healthcare providers; and medical schools and medical Royal Colleges.

Professor Rubin said: "It is an honour and a privilege to become Chair of the General Medical Council. The next few years for the GMC will be challenging and exciting as we continue to deliver a major agenda of change.

"The GMC has a hugely important role in maintaining and assuring patient safety through the highest standards in medicine. I am looking forward to working with doctors, patients, employers and educators alike to ensure we continue to fulfil that role."

20th April 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...